J&J Unit Cuts Deal To End Cancer Drug Trade Secret Fight
By Dorothy Atkins · May 1, 2024, 5:40 PM EDT
A New Jersey federal judge has signed off on a consent judgment that permanently bars Chinese drugmaker Jiangsu Hengrui Pharmaceuticals Co. from misappropriating Johnson and Johnson's pharmaceutical subsidiary Janssen's trade secrets...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login